Citigroup’s leadership changes target subsectors including biotechnology, medical technology, biopharmaceuticals, and acute care.
Rebecca Ungarino is a Senior Wall Street Reporter at Barron's. She specializes in topics related to banking, finance, and investment, including stocks and bonds, asset management, and alternative investments. Rebecca's work has been featured in notable publications such as Business Insider, Yahoo News, and MarketWatch.